Yaling Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yaling Zhou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
B. Fileta
Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC, USA
1 shared publicationB. Reinhardt
Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC, USA
1 shared publicationCraig R. Johnson
Department of Veterinary & Biomedical Sciences, University of Minnesota, St. Paul, MN 55108, USA
1 shared publicationJ. Anderson
Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC, USA
1 shared publicationM. Sjogren
Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC, USA
1 shared publication- Michael Paul Murtaugh
Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN 55108, USA
1 shared publication
Latest Publications
- 28 August 2008
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 33 (3) , 344-352
Species specialization in cytokine biology: Is interleukin-4 central to the TH1–TH2 paradigm in swine?
- 28 August 2008
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 33 (3) , 344-352
Species specialization in cytokine biology: Is interleukin-4 central to the TH1–TH2 paradigm in swine?
- 1 January 2008
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 13 (13) , 1152-70
Regulatory T Cells and viral infections
Viral infections often lead to generalized immunosuppression characterized by the downregulation of virus-specific CD4+ and CD8+ T cell responses and/or non-specific inflammation. One of the mechanisms for the virus-induced immunosuppression is the induction of CD4+ CD25+ regulatory T (Treg) cells that act to suppress effector T cell functions during infection. Depending on the situation, the CD4+ CD25+ Treg cell-mediated suppression can be either beneficial or detrimental to the host. On one hand, they play a critical role in maintaining host homeostasis by controlling exaggerated and destructive inflammations paralleling strong antiviral immune responses and thus contribute to host protection. On the other hand, suppression of virus-specific T cell responses by the Treg cells depresses host antiviral immune responses and thus facilitates viral persistence and disease progression. Despite numerous reports on induction of CD4+ CD25+ Treg cells in viral infections, it is still not fully clear how they are induced and how they act to suppress effector T cell functions in viral infections. This review discusses recent progress in our understanding of the role of virus-induced CD4+ CD25+ Treg cells and the mechanisms by which they are induced and exert their function during infection.
- 1 January 2008
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 13 (13) , 1152-70
Regulatory T Cells and viral infections
Viral infections often lead to generalized immunosuppression characterized by the downregulation of virus-specific CD4+ and CD8+ T cell responses and/or non-specific inflammation. One of the mechanisms for the virus-induced immunosuppression is the induction of CD4+ CD25+ regulatory T (Treg) cells that act to suppress effector T cell functions during infection. Depending on the situation, the CD4+ CD25+ Treg cell-mediated suppression can be either beneficial or detrimental to the host. On one hand, they play a critical role in maintaining host homeostasis by controlling exaggerated and destructive inflammations paralleling strong antiviral immune responses and thus contribute to host protection. On the other hand, suppression of virus-specific T cell responses by the Treg cells depresses host antiviral immune responses and thus facilitates viral persistence and disease progression. Despite numerous reports on induction of CD4+ CD25+ Treg cells in viral infections, it is still not fully clear how they are induced and how they act to suppress effector T cell functions in viral infections. This review discusses recent progress in our understanding of the role of virus-induced CD4+ CD25+ Treg cells and the mechanisms by which they are induced and exert their function during infection.
- 28 August 2007
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 14 (12) , 849-858
Hepatitis C virus E2 envelope protein induces dendritic cell maturation
Summary. Maturation is a critical process for dendritic cells (DC) to gain or enhance their functions in antigen presentation and T‐cell activation. In this study, we investigated the effect of hepatitis C virus (HCV) envelope protein E2 on DC maturation and related functions. We show that binding of E2 protein to DC leads to a change from immature to mature phenotype as detected by an increased expression of cell surface molecules including CD83, CD80, CD86, CD11c and MHC class II. The E2‐matured DC showed higher capacity to stimulate T‐cell proliferation and interferon‐γ production and displayed higher levels of interleukin‐12 production when compared with immature DC. The induction of DC maturation by E2 is both time‐ and dose‐dependent and can be inhibited by anti‐E2 antibodies. In addition, DC matured by E2 showed decreased uptake of bovine serum albumin and latex beads, indicating their decreased activities of endocytosis and phagocytosis upon maturation. Taken together, our results demonstrated that E2 protein is able to induce dendritic cell maturation and suggested that E2 protein may play an important role in regulation of immune responses during HCV infection.
- 28 August 2007
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 14 (12) , 849-858
Hepatitis C virus E2 envelope protein induces dendritic cell maturation
Summary. Maturation is a critical process for dendritic cells (DC) to gain or enhance their functions in antigen presentation and T‐cell activation. In this study, we investigated the effect of hepatitis C virus (HCV) envelope protein E2 on DC maturation and related functions. We show that binding of E2 protein to DC leads to a change from immature to mature phenotype as detected by an increased expression of cell surface molecules including CD83, CD80, CD86, CD11c and MHC class II. The E2‐matured DC showed higher capacity to stimulate T‐cell proliferation and interferon‐γ production and displayed higher levels of interleukin‐12 production when compared with immature DC. The induction of DC maturation by E2 is both time‐ and dose‐dependent and can be inhibited by anti‐E2 antibodies. In addition, DC matured by E2 showed decreased uptake of bovine serum albumin and latex beads, indicating their decreased activities of endocytosis and phagocytosis upon maturation. Taken together, our results demonstrated that E2 protein is able to induce dendritic cell maturation and suggested that E2 protein may play an important role in regulation of immune responses during HCV infection.